Masquelet Technique for Treatment of Posttraumatic Bone Defects

Table 1

Patient demographics.

Patient number/sex/age (y)	Type of injury	Fracture type	Soft tissue condition	Indication	Bone defect, length (cm)	Spacer	Definite fixation	Current State	Duration of cementation (days)
1/M/60	Fracture; distal humerus	Closed	Wound contaminated	Postoperative wound; infection	2 cm	Gentamycin	Plate and screw	Bone grafted and healed	50
2/M/60	Fracture; olecranon	Open Gustilo II	Viable,; not contaminated	Bone loss	2 cm	Vancomycin	Plate and screw	Bone grafted and healed	57
3/M/28	Fracture; distal; femur	Open Gustilo IIIA	Gross infection, contaminated	Postoperative wound infection	8 cm	Gentamycin	Plate and screw	Bone grafted and healed	48
4/F/79	Fracture left olecranon	Closed	Infection deep to joint, contaminated	Postoperative; wound infection	4 cm	Gentamycin; + vancomycin	Plate and screw	Bone grafted and healed	53
5/M/53	Fracture; tibial plateau	Closed	Deep infection extending to knee joint, contaminated	Postoperative; wound infection	4 cm	Gentamycin; + vancomycin	Plate and screw	Bone grafted and healed	48
6/M/48	Fracture; os calcis	Open Gustilo II	Soft tissue viable,; not contaminated	Bone loss	2 cm	Gentamycin	Plate and screw	Bone grafted and healed	30
7/M/61	Fracture; distal femur	Closed	Viable,; not contaminated	Nonunion	3 cm	Gentamycin; + vancomycin	Plate and screw	Bone grafted and healed	43
8/F/27	Fracture; distal; tibia	Open Gustilo II	Not contaminated	Bone loss	2 cm	Gentamycin	Plate and screw	Bone grafted and healed	59
9/M/60	Fracture; distal; tibia	Open Gustilo IIIC	Minimal contaminated	Bone loss	4 cm	Vancomycin	Plate and screw	Bone grafted and healed	49